Try our Advanced Search for more refined results

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. June 15, 2022

    SF Opioid Crisis Not From Allergan's Market Share, Judge Told

    An economics expert for Allergan testified Wednesday in a bellwether opioid bench trial that the "extremely small" market share and promotion done for the company's two branded opioids could not have substantially contributed to San Francisco's opioid crisis.

  2. June 14, 2022

    Remand Denial Raises Question In W.Va. Opiate Litigation

    The West Virginia attorney general on Tuesday asked the Ohio federal judge overseeing the multidistrict litigation over the opioid crisis to clarify under what conditions the state's medical professional liability law applies in suits brought by municipalities against health care providers.

  3. June 13, 2022

    Judge Breyer Pitches Law Chat As SF Opioid Trial Nears End

    With a high-stakes bench trial winding down over San Francisco's claims that Teva, Allergan, Anda and Walgreens illegally fueled the city's opioid epidemic, U.S. District Judge Charles Breyer judge indicated Monday he'd like to schedule a discussion exploring the law governing the case separate from the facts presented at trial.

  4. June 13, 2022

    Ohio Counties Open To Lowering Opioid Damages Request

    Two Ohio counties told a federal judge Monday they still want billions to address the fallout from the opioid epidemic from three large pharmacy chains that a jury found contributed to the crisis, although the counties also said that questions about the size of the impacted population could warrant a smaller payout.

  5. June 10, 2022

    Opioid Judge Disavows 'Unfair' Atty Fees But Still Draws Fire

    The federal judge steering multidistrict opioid litigation revisited a controversial order regarding discovery and attorney fees, but counsel for local governments said Friday that the purported clarification doesn't adequately address a high-profile call for Sixth Circuit intervention.

  6. June 08, 2022

    Drug Industry Didn't Create Nation's Opioid Crisis, Judge Told

    An addiction specialist called by the defense in a bellwether trial over claims Teva, Allergan, Anda and Walgreens illegally fueled San Francisco's opioid epidemic testified Wednesday that American's drug abuse problems predate the increased use of prescription opioids and can be pinned on myriad social, cultural and mental health causes.

  7. June 07, 2022

    DEA Change In Opioid Policy Created Confusion, Judge Hears

    The U.S. Drug Enforcement Administration created "confusion" internally and with prescription drug distributors when it began requiring new suspicious order monitoring systems as opioid use surged around 2006, a San Francisco judge heard Tuesday in recorded testimony played during a bellwether opioid bench trial.

  8. June 02, 2022

    Walgreens Exec Faces Tough Queries From SF Opioid Judge

    A Walgreens executive took the stand in a bellwether opioid bench trial shortly after the city and county of San Francisco rested their case-in-chief Thursday, defending the pharmacy chain's compliance efforts and answering tough questions from the California federal judge presiding over the bench trial.

  9. June 02, 2022

    Panel Rejects Opioid MDL Expansion Despite 'Flood Of Cases'

    The Judicial Panel on Multidistrict Litigation rebuffed pleas from drugstore giants CVS Pharmacy, Walgreens and Walmart to rethink its surprise decision capping multidistrict opioid litigation, shrugging off predictions that opioid cases will spread chaotically in courts across the country.

  10. June 01, 2022

    SF Opioid Judge Told Higher Doses Increased Addiction

    Attorneys for the city of San Francisco sought to bolster their case Wednesday that Allergan, Teva, Walgreens and Anda illegally fueled the city's opioid epidemic by calling experts to testify that rising prescriptions and dosages allegedly pushed by the drug industry contributed to rising addiction rates.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!